Location History:
- Oslo, NO (2017)
- Porsgrunn, NO (1999 - 2020)
Company Filing History:
10 out of 10 
5 out of 5 
1 out of 240 
Years Active: 1999-2020
Title: Innovations in Immunology: The Patented Work of Jon Amund Eriksen
Introduction: Jon Amund Eriksen is a notable inventor hailing from Porsgrunn, Norway, with an impressive portfolio of 17 patents. His work primarily focuses on innovative peptide mixtures aimed at enhancing immune responses. Eriksen's contributions to the field of immunology have garnered attention for their potential applications in therapeutics and disease prevention.
Latest Patents: Among his most recent patents, Jon Amund Eriksen has developed a novel peptide mixture that is particularly significant. This mixture is designed to elicit an immune response and contains two distinct peptides, each corresponding to a fragment of the RAS protein. Each peptide includes a segment of at least 8 amino acids that features position 13 of the RAS protein. Importantly, these segments retain at least 6 amino acid residues that are identical to the corresponding regions of the RAS protein, aside from position 13, which carries a point mutation that differs between the two peptides.
Career Highlights: Throughout his professional journey, Jon Amund Eriksen has made substantial contributions while working with leading biotechnology firms. Notable among these are his roles at Gemvax AS and Targovax ASA, where he leveraged his expertise in immunology to advance therapeutic innovations. His research continues to push the boundaries of our understanding of peptide interactions and immune response modulation.
Collaborations: Eriksen's work has been further enriched through collaborations with esteemed colleagues in the field. Notable collaborators include Gustav Gaudernack and Mona Møller, who have shared their insights and expertise, adding depth to his research initiatives.
Conclusion: Jon Amund Eriksen's innovative efforts in the development of peptide mixtures represent significant strides in immunology. With a total of 17 patents that showcase his commitment to science and research, Eriksen continues to impact the field positively. As his work progresses, it holds promise for advancing therapeutic strategies and improving immune response in various medical contexts.